A Urokinase Receptor-associated Protein with Specific Collagen Binding Properties*

The plasminogen activation cascade system, directed by urokinase and the urokinase receptor, plays a key role in extracellular proteolysis during tissue remodeling. To identify molecular interaction partners of these trigger proteins on the cell, we combined covalent protein cross-linking with mass spectrometry based methods for peptide mapping and primary structure analysis of electrophoretically isolated protein conjugates. A specific tri-molecular complex was observed upon addition of pro-urokinase to human U937 cells. This complex included the urokinase receptor, pro-urokinase, and an unknown, high molecular weight urokinase receptor-associated protein. The tryptic peptide mixture derived from a cross-linked complex of pro-urokinase and the latter protein was analyzed by nanoelectrospray tandem mass spectrometric sequencing. This analysis identified the novel protein as the human homologue of a murine membrane-bound lectin with hitherto unknown function. The human cDNA was cloned and sequenced. The protein, designated uPARAP, is a member of the macrophage mannose receptor protein family and contains a putative collagen-binding (fibronectin type II) domain in addition to 8 C-type carbohydrate recognition domains. It proved capable of binding strongly to a single type of collagen, collagen V. This collagen binding reaction at the exact site of plasminogen activation on the cell may lead to adhesive functions as well as a contribution to cellular degradation of collagen matrices.

[1]  P. Carmeliet,et al.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Pourmotabbed,et al.  The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B. , 1998, Archives of biochemistry and biophysics.

[3]  K. Almholt,et al.  Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. , 1998, Current opinion in cell biology.

[4]  M. Taylor Evolution of a family of receptors containing multiple C-type carbohydrate-recognition domains. , 1997, Glycobiology.

[5]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[6]  L. Liotta,et al.  Proteolytic Enzymes in Cancer Invasion and Metastasis , 1986, Seminars in thrombosis and hemostasis.

[7]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[8]  M. Taylor,et al.  Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. , 1993, The Journal of biological chemistry.

[9]  C. Cabañas,et al.  Structural requirements for alpha 1 beta 1 and alpha 2 beta 1 integrin mediated cell adhesion to collagen V. , 1996, Journal of cell science.

[10]  F. Blasi,et al.  Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.

[11]  M. Scully,et al.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.

[12]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. , 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

[13]  N. Kikuchi,et al.  Molecular cloning of pancreatic group I phospholipase A2 receptor. , 1994, The Journal of biological chemistry.

[14]  S. Ho,et al.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. , 2013, BioTechniques.

[15]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[16]  M. Taylor,et al.  Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. , 1990, The Journal of biological chemistry.

[17]  J. Reynolds,et al.  The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinases a , 1992 .

[18]  M. Lazdunski,et al.  Cloning and expression of a membrane receptor for secretory phospholipases A2. , 1994, The Journal of biological chemistry.

[19]  Thomas E. Creighton,et al.  Protein structure : a practical approach , 1997 .

[20]  R. Stephens,et al.  The urokinase receptor , 1998 .

[21]  K. Danø,et al.  A novel, specific pro‐urokinase complex on monocyte‐like cells, detected by transglutaminase‐catalyzed cross‐linking , 1993, FEBS letters.

[22]  M. Lazdunski,et al.  Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2. , 1995, Biochemistry.

[23]  Toshihiko Hayashi,et al.  Basement-membrane stromal relationships: interactions between collagen fibrils and the lamina densa. , 1997, International review of cytology.

[24]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[25]  J. Zeuthen,et al.  Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies. , 1986, Journal of immunoassay.

[26]  H. Vorum,et al.  Mannose 6-Phosphate/Insulin-like Growth Factor–II Receptor Targets the Urokinase Receptor to Lysosomes via a Novel Binding Interaction , 1998, The Journal of cell biology.

[27]  L. Zanetta,et al.  Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants , 1997, The EMBO journal.

[28]  D. Loskutoff,et al.  Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? , 1996, The Journal of cell biology.

[29]  D. Sane,et al.  Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. , 1990, The Journal of biological chemistry.

[30]  M. Lazdunski,et al.  Identification of the Binding Domain for Secretory Phospholipases A2 on Their M-type 180-kDa Membrane Receptor * , 1995, The Journal of Biological Chemistry.

[31]  A. Podtelejnikov,et al.  Delayed extraction improves specificity in database searches by matrix-assisted laser desorption/ionization peptide maps. , 1996, Rapid communications in mass spectrometry : RCM.

[32]  D. Belin,et al.  Characterization of the cellular binding site for the urokinase-type plasminogen activator. , 1989, The Journal of biological chemistry.

[33]  E. Appella,et al.  The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. , 1990, The Journal of biological chemistry.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  F. Blasi,et al.  Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect. , 1996, The EMBO journal.

[36]  D. Eyre,et al.  Bone type V collagen: chain composition and location of a trypsin cleavage site. , 1989, Connective tissue research.

[37]  H. Pannekoek,et al.  Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .

[38]  M Wilm,et al.  Peptide Sequencing by Mass Spectrometry for Homology Searches and Cloning of Genes , 1997, Journal of protein chemistry.

[39]  T. Pawson,et al.  The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.

[40]  A. Podtelejnikov,et al.  Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. , 1997, Analytical chemistry.

[41]  M. Ploug,et al.  Cellular receptor for urokinase-type plasminogen activator: protein structure. , 1993, Methods in enzymology.

[42]  L. Lasky,et al.  Characterization of a Novel Member of the Macrophage Mannose Receptor Type C Lectin Family* , 1996, The Journal of Biological Chemistry.

[43]  A. Vaheri,et al.  Ultrastructural localization of plasma membrane-associated urokinase- type plasminogen activator at focal contacts , 1988, The Journal of cell biology.

[44]  M. Lazdunski,et al.  Endocytic Properties of the M-type 180-kDa Receptor for Secretory Phospholipases A(*) , 1996, The Journal of Biological Chemistry.

[45]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[46]  D. Eyre,et al.  A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. , 1994, Biochemical and biophysical research communications.

[47]  G. Yancopoulos,et al.  An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.

[48]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[49]  M. Ploug,et al.  Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptor , 1991, FEBS letters.

[50]  P. Bornstein,et al.  Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen , 1984, The Journal of cell biology.

[51]  F. Ruggiero,et al.  Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. , 1994, Experimental cell research.

[52]  M. Taylor,et al.  Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. , 1992, The Journal of biological chemistry.

[53]  O. Majdic,et al.  Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. , 1996, Blood.

[54]  J. Kleman,et al.  Another look at collagen V and XI molecules. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[55]  F. Blasi,et al.  A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. , 1988, The Journal of biological chemistry.

[56]  K. Danø,et al.  Domain Interplay in the Urokinase Receptor , 1996, The Journal of Biological Chemistry.

[57]  A. Shevchenko,et al.  Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry , 1996, Nature.

[58]  M. Wilm,et al.  Error-tolerant identification of peptides in sequence databases by peptide sequence tags. , 1994, Analytical chemistry.

[59]  L. Patthy,et al.  The collagen-binding site of type-II units of bovine seminal fluid protein PDC-109 and fibronectin. , 1990, European journal of biochemistry.

[60]  L. Patthy,et al.  The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). , 1994, The Biochemical journal.

[61]  Y. Sasaguri,et al.  Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.

[62]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[63]  A. Podtelejnikov,et al.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Michael V. Doyle,et al.  Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.

[65]  P. Dombernowsky,et al.  Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer. , 1988, The Journal of laboratory and clinical medicine.

[66]  T. Bugge,et al.  Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency , 1996, Cell.

[67]  H. Petty,et al.  Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. , 1997, The Journal of laboratory and clinical medicine.